RecruitingHeart FailureDiabetes
Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes
Eligible age
All ages
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
A pragmatic electronic health record (EHR) based randomized controlled trial to evaluate the utility of providing Ultromics EchoGo analysis results and recommendations for HF risk prevention therapies using an EHR embedded clinical decision support tool.
Sponsor: University of Texas Southwestern Medical Center
You may qualify if…
- ✓ Patients with diagnosis of Type 2 diabetes and High WATCH DM score.
- ✓ Echocardiogram available in last 6-months.
You may not qualify if…
- ✕ History of HF
- ✕ Not eligible for prescription of new GLP-1RA or SGLT2i or ns-MRA
- ✕ Corresponding providers to patients identified by the above inclusion exclusion criteria will be included in the clinical trial of the decision support tool.
Where it's recruiting
Texas
Dallas
Source: ClinicalTrials.gov · NCT06593314 · last updated 2026-05-07